YD Bio Limited Ordinary Shares

YDES | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.63

-$0.56 (-17.55%)

At close: Sep 21, 2026, 4:00 PM ET

$2.61

-$0.02 (-0.76%)

Pre-market: Sep 22, 2026, 8:26 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-389.19K	-353.82K	-381.29K	-260.08K	-537.41K	-1.05M	-506.73K
Interest Income	34.58K	34.56K	122.08K	135.54K	170.99K	169.58K	167.64K
Pretax Income	-2.22M	-3.37M	417.79K	2.18M	17.11M	-22.01M	676.42K
Net Income	-2.21M	-3.37M	417.79K	2.19M	17.1M	-22.02M	692.04K
Selling & General & Admin	389.19K	353.82K	381.29K	260.08K	537.41K	1.05M	506.73K
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	389.19K	353.82K	381.29K	260.08K	537.41K	1.05M	506.73K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	389.19K	353.82K	381.29K	260.08K	537.41K	1.05M	506.73K
Income Tax Expense	-1.68K	1.76K	n/a	-12.04K	6.26K	5.78K	-15.63K
Shares Outstanding (Basic)	3.41M	3.42M	4.03M	4.03M	4.22M	4.3M	4.3M
Shares Outstanding (Diluted)	3.41M	3.42M	4.03M	4.03M	4.22M	4.3M	4.3M
EPS (Basic)	-0.65	-0.98	0.10	0.54	4.05	-5.12	0.16
EPS (Diluted)	-0.65	-0.98	0.10	0.54	4.05	-5.12	0.16
EBITDA	-2.22M	-3.37M	417.79K	2.18M	17.11M	-22.01M	676.42K
EBIT	-2.22M	-3.37M	417.79K	2.18M	17.11M	-22.01M	676.42K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a